Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

June 05, 2020 07:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies to Present at the Virtual Summer Summit on June 9th

NEWTOWN, Pa., June 05, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
May 12, 2020 07:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. Announces FDA Has Granted the PoNS Device Breakthrough Device Designation for the Treatment of Gait Deficits Due to Symptoms of Multiple Sclerosis

NEWTOWN, Pa., May 12, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
May 07, 2020 16:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook

NEWTOWN, Pa., May 07, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
April 30, 2020 12:01 ET | Source: Helius Medical Technologies, Inc.

UPDATE -- Helius Medical Technologies, Inc. Announces Publication of its PoNS™ Registrational Clinical Trial (TBI-001) in TBI

NEWTOWN, Pa., April 30, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
April 22, 2020 16:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies to Release First Quarter of Fiscal Year 2020 Financial Results on May 7, 2020

NEWTOWN, Pa., April 22, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
April 22, 2020 07:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies Appoints Jeffrey S. Mathiesen to its Board of Directors

NEWTOWN, Pa., April 22, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ: HSDT) (TSX: HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
March 24, 2020 07:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies Announces Authorization from Health Canada to Market the PoNS™ Device for the Treatment of Gait Deficit Due to Mild and Moderate Multiple Sclerosis (MS)

NEWTOWN, Pa., March 24, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), today announced that its Canadian Class II license amendment...
March 18, 2020 08:00 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies Announces $2.2 Million Registered Direct Offering

NEWTOWN, Pa., March 18, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness,...
March 12, 2020 16:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. Reports Fourth Quarter and Full Year 2019 Financial Results; Introduces Full Year 2020 Outlook

NEWTOWN, Pa., March 12, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...
March 09, 2020 07:05 ET | Source: Helius Medical Technologies, Inc.

Helius Medical Technologies, Inc. Provides Details on Five Recently Authorized PoNS Treatment™ Clinics

NEWTOWN, Pa., March 09, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (Nasdaq: HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today...